Profile
Susan Schneider worked as a Director of Clinical & Scientific Affairs at Bausch & Lomb, a Medical Director at Genentech, a Senior Director of Ophthalmology at GlaxoSmithKline LLC, a Chief Medical Officer at Beacon Therapeutics (USA), Oxurion NV, and Santen, Inc. She also worked as a Principal at New York Eye & Ear Infirmary and The University of Cincinnati College of Medicine.
Schneider completed her undergraduate degree at the University of Pennsylvania.
Former positions of Susan Schneider
Companies | Position | End |
---|---|---|
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Corporate Officer/Principal | 2021-09-30 |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | - |
The University of Cincinnati College of Medicine | Corporate Officer/Principal | - |
OXURION NV | Chief Tech/Sci/R&D Officer | - |
New York Eye & Ear Infirmary | Corporate Officer/Principal | - |
Training of Susan Schneider
University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OXURION NV | Health Technology |
Private companies | 6 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Susan Schneider